Phase 3 Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who were previously enrolled in one of four specific related studies (NCT05784246, NCT04004611, NCT03926130, or NCT05509777) and whose doctor believes they would benefit from continuing treatment with mirikizumab
- People from those previous studies who completed all required visits and assessments at the end of that study while still taking the study medication
- Female participants who agree to use contraception as required by the trial
Who may not be able to join:
- People who experienced a serious harmful reaction or medical event during their previous study, or who developed another condition, that would make continuing mirikizumab too risky
- People who had to permanently or temporarily stop taking the study medication during their previous study in a way that would make restarting mirikizumab unsafe
- People who have an unstable or poorly controlled illness that could affect their safety during the trial
- People whose participation in the trial could, for any reason, put their safety at risk or make the study results harder to interpret
- People who have non-cancerous growths (polyps) in the bowel that have not yet been removed
- People who are pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company
Phone: 1-317-615-4559
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of Participants with UC in Modified Mayo Score (MMS) Clinical Remission; Percentage of Participants with CD in Pediatric Crohn's Disease Activity Index (PCDAI) Clinical Remission
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.